The effect of auricular acupressure therapy (AAT) on chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer patients

Chungnam National University0 个研究点目标入组 120 人开始时间: 待定最近更新: 2020年4月21日

试验速览

暂无简介。

•female, at least 20 and under 65years old
•patients diagnosed with primary breast cancer
•patients with a diagnosis of Taxane-induced peripheral neuropathy presenting within the last week of an average pain score of at least 5 on a numeric rating scale
•patients with an ECOG (Eastern Cooperative Oncology Group) performance status of 2 or less
•patients who are willing and able to comply with the requirements of the study
•patients who are willing and able to provide written informed consent

•Patients with symptoms of peripheral neuropathy that are severe and need to be immediately treated with surgical procedures or acute management
•Patients with skin inflammation at the attachment site
•Wearing a hearing aid and piercing
•Elapsed 12-months after the end of chemotherapy
•Participants with a history of previous experience of an auricular therapy before enrollment
•Patients with dementia or cognitive impairment that may affect this study
•Patients who do not have the ability to read, understand, or respond to questionnaires
•Receiving Chemotherapy and radiotherapy during the period of the study
•Patients with a history of receiving other intervention programs during the study
•Patients with other reasons not to comply with this study protocol

发起方